Authors: OSE L SCOTT R BRUSCO O UGARTE AC DESCAMPS O HELLER F PAQUOT N SCHEEN A BERTOLAMI MC FORTI N RICHTER W SELMAIER A ZIEGLASCH HJ KLOER H BADE R WANNER C KOESTER W KRAEMERGUTH A BILIANOU H LEFKOS N EFTHIMIADIS A KASTELEIN J VANDAM M VANDEWIEL A LINTOTT C SUNDT E ISTAD H LOENNECHEN CW UTNE E HOLE T SKARE S URHEIM S CAMPODINCO S MORALES R IZA A ALVAREZ L SY R YEBES R LEE CY TAN A QUEK S VERMAK WJH VORSTER HH RAAL FJ KELLER U NOSEDA G BONETTI T CRAWFORD GM BLOOMFIELD P SUTHERLAND K RYLANCE PB BROOM J BAKSI AK LANT AF HUGHES EA

Citation: L. Ose et al., DOUBLE-BLIND COMPARISON OF THE EFFICACY AND TOLERABILITY OF SIMVASTATIN AND FLUVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Clinical drug investigation, 10(3), 1995, pp. 127-138

Authors: ODUM J RYLANCE PB JACKSON MA

Citation: J. Odum et al., FROM WOLVERHAMPTON TO BOMBAY, Lancet, 343(8899), 1994, pp. 734-734

Authors: BEHOUNEK BD MARKOWITZ JS BERGMAN M MCGOVERN ME KASSLERTAUB KB VANHANEN H ELORANTA M JUVONEN J KANTOLA I KEKKI S KIVELA H KNUTAR F NISSEN M SALMI J SALONEN R TARPILA S TUNTURIHIHNALA H AMANN FW BERENDES G BONNER G DUBACH UC EGGSTEIN M FRANKENBERG HV FROER KL HOHL H HOPPE F KUMMER H MARZ W MOCCETTI T NOSEDA G REUTTER FW SCHWENKE R VOSSCHULTE G WAMBACH G WEIDMANN P BONNIER JJRM DEWEERD P HUIGE MC JANSEN LJ TERIJDT AJ TEVELDE K OLSSON AG LARSSON H ASPLUND J DAHLQVIST A LONNQVIST F FRITHZ G HOGLUND C KJELLSTROM T KUYLENSTIERNA J MOLLER B OSTERGREN J CRAMB R DAVIES J",IVERSON,"JOHNSTON GD MUNRO A PEACOCK I RITCHIE LD RITTER J RYLANCE PB SEVER PS SIMMONS RL

Citation: Bd. Behounek et al., EFFECTS OF PRAVASTATIN IN PATIENTS WITH SERUM TOTAL CHOLESTEROL LEVELS FROM 5.2 TO 7.8 MMOL LITER (200 TO 300 MG DL) PLUS 2 ADDITIONAL ATHEROSCLEROTIC RISK-FACTORS, The American journal of cardiology, 72(14), 1993, pp. 1031-1037